179 related articles for article (PubMed ID: 11290542)
21. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer.
Shariat SF; Tokunaga H; Zhou J; Kim J; Ayala GE; Benedict WF; Lerner SP
J Clin Oncol; 2004 Mar; 22(6):1014-24. PubMed ID: 14981102
[TBL] [Abstract][Full Text] [Related]
22. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
23. Validation of tissue microarray for the immunohistochemical profiling of melanoma.
Pacifico MD; Grover R; Richman P; Daley F; Wilson GD
Melanoma Res; 2004 Feb; 14(1):39-42. PubMed ID: 15091192
[TBL] [Abstract][Full Text] [Related]
24. Parathyroid neoplasms: clinical, histopathological, and tissue microarray-based molecular analysis.
Stojadinovic A; Hoos A; Nissan A; Dudas ME; Cordon-Cardo C; Shaha AR; Brennan MF; Singh B; Ghossein RA
Hum Pathol; 2003 Jan; 34(1):54-64. PubMed ID: 12605367
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients.
Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR
Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948
[TBL] [Abstract][Full Text] [Related]
26. Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.
Cordon-Cardo C; Zhang ZF; Dalbagni G; Drobnjak M; Charytonowicz E; Hu SX; Xu HJ; Reuter VE; Benedict WF
Cancer Res; 1997 Apr; 57(7):1217-21. PubMed ID: 9102201
[TBL] [Abstract][Full Text] [Related]
27. Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer.
Donati V; Faviana P; Dell'omodarme M; Prati MC; Camacci T; De Ieso K; Giannini R; Lucchi M; Mussi A; Pingitore R; Basolo F; Fontanini G
Hum Pathol; 2004 Nov; 35(11):1347-52. PubMed ID: 15668891
[TBL] [Abstract][Full Text] [Related]
28. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical study of DNA topoisomerase I, p53, and Ki-67 in uterine carcinosarcomas.
Lee SJ; Kim HS; Kim HS; Chun YK; Hong SR; Lee JH
Hum Pathol; 2007 Aug; 38(8):1226-31. PubMed ID: 17490723
[TBL] [Abstract][Full Text] [Related]
31. Polyoma virus-associated cellular changes in the urine and bladder biopsy samples: a cytohistologic correlation.
Herawi M; Parwani AV; Chan T; Ali SZ; Epstein JI
Am J Surg Pathol; 2006 Mar; 30(3):345-50. PubMed ID: 16538054
[TBL] [Abstract][Full Text] [Related]
32. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
33. A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays.
Huang W; Hennrick K; Drew S
Hum Pathol; 2013 Jan; 44(1):29-38. PubMed ID: 22944297
[TBL] [Abstract][Full Text] [Related]
34. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
35. Gene expression profiling reveals Ki-67 associated proliferation signature in human glioblastoma.
Jin Q; Zhang W; Qiu XG; Yan W; You G; Liu YW; Jiang T; Wang L
Chin Med J (Engl); 2011 Sep; 124(17):2584-8. PubMed ID: 22040407
[TBL] [Abstract][Full Text] [Related]
36. Gene Expression Profiling of Desmoid Tumors by cDNA Microarrays and Correlation with Progression-Free Survival.
Salas S; Brulard C; Terrier P; Ranchere-Vince D; Neuville A; Guillou L; Lae M; Leroux A; Verola O; Jean-Emmanuel K; Bonvalot S; Blay JY; Le Cesne A; Aurias A; Coindre JM; Chibon F
Clin Cancer Res; 2015 Sep; 21(18):4194-200. PubMed ID: 25878329
[TBL] [Abstract][Full Text] [Related]
37. Low-grade fibromyxoid sarcoma versus fibromatosis: a comparative study of clinicopathological and immunohistochemical features.
Meng GZ; Zhang HY; Bu H; Geng JG
Diagn Cytopathol; 2009 Feb; 37(2):96-102. PubMed ID: 19021197
[TBL] [Abstract][Full Text] [Related]
38. Tissue microarrays in non-small-cell lung cancer: reliability of immunohistochemically-determined biomarkers.
Pøhl M; Olsen KE; Holst R; Ditzel HJ; Hansen O
Clin Lung Cancer; 2014 May; 15(3):222-230.e3. PubMed ID: 24486059
[TBL] [Abstract][Full Text] [Related]
39. Comparison of tissue microarray and full section in immunohistochemistry of gastrointestinal stromal tumors.
Kwon MJ; Nam ES; Cho SJ; Park HR; Shin HS; Park JH; Park CH; Lee WJ
Pathol Int; 2009 Dec; 59(12):851-6. PubMed ID: 20021609
[TBL] [Abstract][Full Text] [Related]
40. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]